PIONEER 3: Head-to-head vs Januvia (sitagliptin) 1,4 Study design: 78-week, randomized, double-blind, double-dummy, active controlled, parallel-group, phase 3a trial designed to assess the efficacy and assess long-term adverse event profile of once-daily semaglutide tablets vs Januvia in addition to metformin with or without sulfonylurea
Kautz A, Meng Y, Yeh KL, et al
Scenesse is available as subcutaneous implants, which provide more favorable pharmacokinetics than regular injections [4]
[24] [25] Weight management medications (including GLP-1 receptor agonists and orlistat) should generally be deferred until after weaning, unless exceptional circumstances warrant earlier intervention with careful risk-benefit assessment by specialists
It is reported here neutrally as a genuine caveat
Choose fiber-boosting add-ins when possible